EARLY ANTIBODY THERAPY CAN INDUCE LONG LASTING IMMUNITY TO SHIV

Highly potent and broadly neutralizing anti-HIV-1 antibodies (bNAbs) have been used to prevent and treat lentivirus infections in humanized mice, macaques and humans(1–12). To determine whether the administration of combination bNAbs during the acute SHIV infection of rhesus macaques might lead to l...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nature
Asıl Yazarlar: Nishimura, Yoshiaki, Gautam, Rajeev, Chun, Tae-Wook, Sadjadpour, Reza, Foulds, Kathryn E., Shingai, Masashi, Klein, Florian, Gazumyan, Anna, Golijanin, Jovana, Donaldson, Mitzi, Donau, Olivia K., Plishka, Ronald J., Buckler-White, Alicia, Seaman, Michael S., Lifson, Jeffrey D., Koup, Richard A., Fauci, Anthony S., Nussenzweig, Michel C., Martin, Malcolm A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458531/
https://ncbi.nlm.nih.gov/pubmed/28289286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature21435
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller